Fig. 2From: Participation of the elderly, women, and minorities in pivotal trials supporting 2011–2013 U.S. Food and Drug Administration approvalsSample construction of novel therapeutic agents approved by the U.S. Food and Drug Administration (FDA) between 2011 and 2013, including associated indications and identified pivotal trialsBack to article page